LINK Medical, the Northern European clinical research organisation (CRO), is making moves to boost its role as a bridge between the Nordics and Germany’s vast medical devices and pharmaceuticals markets.
The firm is establishing a stronger position in Germany with the appointment of new German-based medical device director, Erwin de Buijzer.
While also growing its German team, the company aims to give global clients access to Germany’s well-recognised regulatory authorities and network of clinical trial sites and investigators. Germany is also home to Europe’s largest patient population – another key element for performing high-quality clinical trials.
LINK provides a range of product development services for the pharmaceutical and medical device industries.
It helps established and start-up companies develop their products, from the concept stage to commercialisation; and aims to improve and accelerate health products through “transformative methods, active communication and optimal solutions”.
Its German office was established in 2015 and since then has expanded to cover medical device consultancy, clinical operations and regulatory services.
With a leadership background in the medical device sector, as well as a business education and experience as a medical doctor, de Buijzer brings considerable medical device expertise to LINK Medical and the German team.
He said: “I am excited to be joining such a dedicated team, committed to facilitating customers worldwide in achieving market success for their medical devices. I am keen to add my knowledge and experience to this diverse network, ensuring LINK Medical can continue supplying exceptional support to clients across the medical device industry.”
Dr. Uwe Anzenberger, general manager, added: “LINK Medical’s continued growth beyond the Nordics, including the addition of Erwin to our team, will help us support our customers in Germany and beyond as they bring their medical device to market. We are excited to see what the future will hold with our strengthened capacity to help customers, regardless of their location.”
LINK currently has over 200 employees. Its early development, clinical Development and market Access teams have helped cultivate a number of products to the European market, including